Figure 2 | Scientific Reports

Figure 2

From: Increased expression of TBC1D10B as a potential prognostic and immunotherapy relevant biomarker in liver hepatocellular carcinoma

Figure 2

The mRNA and protein expression of TBC1D10B in LIHC. (A) Expression of TBC1D10B mRNA in 50 LIHC and 374 adjacent normal samples. (B) The mRNA expression of TBC1D10B in GEO database (GSE45267, GSE101685 and GSE87630). (C,D) The protein expression levels of TBC1D10B based on CPTAC and HPA database. (E) The expression level of TBC1D10B phosphoprotein (NP_056342.3, S132 site) between primary liver cancer tissue and normal tissue was analyzed via UALCAN. (F,G) mRNA levels (F) and protein levels (G) of TBC1D10B in human hepatoma cell lines (Huh-7, Bel7402 and Sk-hep-1) and non-tumor human embryo liver cell (WRL68) were determined by q-RT-PCR and Western blotting. *P < 0.05; ***P < 0.001.

Back to article page